tiprankstipranks
Advertisement
Advertisement
Atara Biotherapeutics upgraded to Hold from Sell at Freedom Broker
PremiumThe FlyAtara Biotherapeutics upgraded to Hold from Sell at Freedom Broker
4M ago
Manufacturing and Supply-Chain Risks Threaten Atara Biotherapeutics’ Cell Therapy Pipeline
Premium
Company Announcements
Manufacturing and Supply-Chain Risks Threaten Atara Biotherapeutics’ Cell Therapy Pipeline
4M ago
Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c
Premium
The Fly
Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c
4M ago
Atara Biotherapeutics trading resumes
PremiumThe FlyAtara Biotherapeutics trading resumes
4M ago
Morning News Wrap-Up, 5/7/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up, 5/7/26: Today’s Biggest Stock Market Stories!
4M ago
Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel
Premium
Company Announcements
Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel
4M ago
Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel 
PremiumClass ActionAtara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel 
5M ago
Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects
Premium
Class Action
Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects
5M ago
Atara Biotherapeutics files to sell 400K shares of common stock for holders
Premium
The Fly
Atara Biotherapeutics files to sell 400K shares of common stock for holders
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100